ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation and Chemoprotective Therapy in Treating Patients With Cancer

This study is ongoing, but not recruiting participants.
Study NCT00003425.   Last updated on November 16, 2008.   Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Breast Cancer
Leukemia
Lymphoma
Neuroblastoma
Ovarian Cancer
Sarcoma
2 Additional conditions recognized in this trial
Breast Neoplasms
Lymphoma, Non-Hodgkin
Multiple Myeloma
Neoplasms, Plasma Cell
Ovarian Neoplasms
3 More general conditions related to this trial
Adnexal Diseases
Blood Protein Disorders
Breast Diseases
Cardiovascular Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Neuroectodermal Tumors, Primitive, Peripheral
Ovarian Diseases
Paraproteinemias
Skin Diseases
Urogenital Neoplasms
Vascular Diseases
4 Interventions listed in this trial
amifostine trihydrate
cyclophosphamide
filgrastim
melphalan
5 Additional drug interventions recognized in this trial
Amifostine
6 More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Therapeutic Uses
7 Sponsors listed in this trial
Lucille P. Markey Cancer Center at University of Kentucky




Links to all studies - primarily for crawlers